...
首页> 外文期刊>Journal of neurology >Four novel mutations of the myelin protein zero gene presenting as a mild and late-onset polyneuropathy.
【24h】

Four novel mutations of the myelin protein zero gene presenting as a mild and late-onset polyneuropathy.

机译:髓磷脂蛋白零基因的四个新突变表现为轻度和迟发性多发性神经病。

获取原文
获取原文并翻译 | 示例
           

摘要

Inherited neuropathies caused by mutations of the major structural protein of peripheral myelin, myelin protein zero (MPZ), contribute to 5% of all cases of Charcot-Marie-Tooth disease (CMT). They can be divided into an early-onset neuropathy with symptoms prior to the stage of walking, and a late-onset neuropathy with symptoms at the age of 40 and older. In this study, five patients with four novel MPZ mutations were identified by molecular genetic testing which presented as mild and late-onset neuropathies. We recommend testing for MPZ mutations in patients with a late-onset neuropathy, as late-onset inherited neuropathies might be more frequent than previously thought.
机译:由周围髓鞘的主要结构蛋白突变,髓磷脂蛋白零(MPZ)引起的遗传性神经病占所有夏科-玛丽齿病(CMT)病例的5%。他们可以分为在行走阶段之前出现症状的早发性神经病和在40岁以上年龄段出现症状的迟发性神经病。在这项研究中,通过分子遗传学测试鉴定了五名具有四个新的MPZ突变的患者,这些患者表现为轻度和迟发性神经病。我们建议对迟发性神经病患者进行MPZ突变测试,因为迟发性遗传性神经病可能比以前认为的更为频繁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号